Utilisation du ligament artificiel LARS dans le traitement de la luxation acromion-claviculaire. Résultats à long terme au recul moyen de 7,4 ans - 13/04/18
The use of the LARS system in the treatment of AC joint instability. Long-term results after a mean of 7.4 years
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
The acromioclavicular (AC) joint is of great importance for shoulder stability and one of the most frequently injured regions of the shoulder.
Hypothesis |
AC joint reconstruction with the ligament augmentation & reconstruction system (LARS™) leads to a good-to-excellent outcome at long-term follow-up.
Patients and methods |
This study was performed as a retrospective single-centre data analysis of a level-I trauma centre. All patients treated operatively for an acute AC dislocation with the LARS™ between 2003 and 2013 were included.
Results |
The study group consisted of three female (6%) and 44 male patients (94%) with an average age of 37 years and a minimum follow-up of two years. The overall mean clinical outcomes at latest follow-up were: Constant 93, DASH 2.64, ASES 96, SST 97, UCLA 34 and VAS 0.4 – representing a good-to-excellent outcome in all patients. Overall, 45 patients (96%) reported to be very satisfied with the achieved result at latest follow-up. In five patients (11%) complications occurred during the follow-up period, requiring surgical revision in four of the five patients (80%).
Conclusion |
AC joint reconstruction with the LARS™ achieves good-to-excellent clinical and functional outcomes at long-term follow-up with a surgical revision rate of 8.5%.
Level of evidence |
Retrospective follow-up study, case series, level IV.
Le texte complet de cet article est disponible en PDF.Keywords : AC joint reconstruction, LARS™, Clinical outcome, Functional outcome, Long-term follow-up, Rockwood III-V
☆ | Cet article peut être consulté in extenso dans la version anglaise de la revue Orthopaedics & Traumatology: Surgery & Research sur Science Direct (sciencedirect.com) en utilisant le DOI ci-dessus. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?